Studies have found that CAFs can increase the ratio of Bcl-2/BAX through the SDF-1/CXCR4/PI3K/AKT signalling pathway, thereby inhibiting the apoptosis of Huh7 cells and promoting HCC progression. The gene discussed is BCL2; the disease is hepatocellular carcinoma.